Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma

BACKGROUND AND OBJECTIVE: A quantitative tumor response evaluation to molecular-targeting agents in advanced renal cell carcinoma (RCC) is debatable. We aimed to evaluate the relationship between radiologic tumor response and pathological response in patients with advanced RCC who underwent presurgi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Hosogoe, Shogo, Hatakeyama, Shingo, Kusaka, Ayumu, Hamano, Itsuto, Tanaka, Yoshimi, Hagiwara, Kazuhisa, Hirai, Hideaki, Morohashi, Satoko, Kijima, Hiroshi, Yamamoto, Hayato, Tobisawa, Yuki, Yoneyama, Tohru, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ohyama, Chikara
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2017
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5564804/
https://ncbi.nlm.nih.gov/pubmed/28572534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17930
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia